+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment for Barretts syndrome

Treatment for Barretts syndrome

Official Gazette of the United States Patent & Trademark Office Patents 1262(4), Sep 24

An apparatus and method for treating Barrett's tissue by removal of the mucosa through PhotoDynamic Therapy(PDT) is provided. A viscous gel is the medium used to carry the photosensitizer to the treatment site and allow sufficient time to transfer to the tissue. The gel's viscosity will allow it to adhere to the tissue for a sufficient amount of time to transfer the photosensitizer or sufficient time for a mechanical device such as an expanding balloon to press the gel into the tissue. The photosensitizer within the gel is activated by the corresponding wavelength of radiation. An extended multi-balloon system limits the area of treatment and localizes the spread of the gel. An endoscope with fiber optics may be used to view the operation. A preferred embodiment of the apparatus contains a catheter with at least two balloons, one to block drainage of the photosensitizer into the stomach and one to limit the height of the treatment area and to press the gel into the tissue. Included in this embodiment is a tube for the delivery of the gel, a tube for cooling purposes or aspiration, an image bundle and a diffuse light source. The apparatus and method may be used to treat various other diseases involving the gastrointestinal diseases of the mucosa. The most salient feature of this invention is the multi-balloon system used to limit the area of treatment, but effect the entire desired area at one time.

(PDF emailed within 1 workday: $29.90)

Accession: 035980166

Download citation: RISBibTeXText

Related references

Barretts-oesophagus, Barretts-dysplasia, Barretts-carcinoma The endoscopic diagnosis with no biopsy is inadequate. Gastroenterology 112(4 SUPPL ): A674, 1997

Analysis of Barretts esophagus causes and risk factors for dysplasia and drug treatment to reverse dysplasia in Barretts esophagus. American Journal of Gastroenterology 98(9 Supplement): S27, September, 2003

CD44st and CD44v6 splice variant expression in Barretts esophagus and Barretts adenocarcinoma. Gastroenterology 112(4 SUPPL ): A595, 1997

Expression of trefoil factors in Barretts esophagus, dysplasia and adenocarcinoma arising in Barretts. Laboratory Investigation 82(1): 124A-125A, January, 2002

A multigene expression panel for the molecular diagnosis of Barretts esophagus and Barretts cancers. Gastroenterology 122(4 Suppl 1): A 16-A 17, April, 2002

Barretts erosions and Barretts ulcers Complications of pathological gastro-esophageal reflux?. Gastroenterology 104(4 SUPPL ): A46, 1993

Is the length of Barretts mucosa related to the prevalence of complications and adenocarcinoma in Barretts esophagus?. Gastroenterology 104(4 SUPPL ): A393, 1993

P53 protein overexpression in Barretts adenocarcinoma and Barretts esophagus in paraffin embedded tissue. Gastroenterology 104(4 SUPPL ): A1045, 1993

Telomerase reverse transcriptase activation in Barretts esophagus and Barretts adenocarcinomas. Gastroenterology 116(4 PART 2): A1331, April, 1999

Telomerase reverse transcriptase activation in Barretts esophagus and Barretts associated adenocarcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 40: 264, March, 1999

Gastric Helicobacter pylori infection is associated with Barretts adenocarcinoma but not Barretts esophagus. Gastroenterology 116(4 PART 2): A319, April, 1999

Prospective evaluation of the association of gastric H pylori infection with Barretts dysplasia and Barretts adenocarcinoma. Gastroenterology 114(4 PART 2): A703, April 15, 1998

Altered pain perception in patients with Barretts esophagus is not related to the length of Barretts mucosa. Gastroenterology 112(4 SUPPL ): A132, 1997

Multilayered epithelium in barretts esophagus relationship to gender, length of barretts, neoplasia, and inflammation. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No W1267, 2003

Expression and functional characterization of PPARgamma in human Barretts epithelium and Barretts adenocarcinoma cells. Gastroenterology 122(4 Suppl 1): A-348, April, 2002